Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
2241-A PREVALENCE OF HEPATIC STEATOSIS IN A MEXICAN THIRD LEVEL HOSPITAL AND RISK FACTORS FOR DEVELOPMENT OF CIRRHOSIS Jos Alonso vila Rojo 1 , Esmeralda Avila Rojo 1 , David Aguirre-Villarreal 2 , Ernesto Elizondo Zepeda 1 and Ignacio Garca Jurez 3 , (1)Instituto Nacional De Ciencias Mdicas y Nutricin Salvador Zubirn, (2)Instituto Nacional de Ciencias Medicas y Nutricion, (3)Instituto Nacional De Ciencias Medicas y Nutricion Background: Non-alcoholic fatty liver disease (NAFLD) has become a growing concern worldwide, with hepatic steatosis being a key component of its pathogenesis
Retourner aux autres fiches de normes biologiques BIOCHIMIE SANGUINE Lipase Sources Lipase sur eurofins-biomnis.com Mmento 100% visuel des bilans sanguins, Hlne Diot, 2024, Vuibert Mmo examens biologiques, Kubab, Hakawati, Alajati-Kubab, ditions Lamarre, 2009 I
For high-quality, sterile injectable forms, patients can expect to pay on the higher end of the scale
SVI1C ranged from 1035.92 to 1841.18, with a mean of 1400.40
